March 30, 2020 

LifeMax Launches AmMax Bio Following The License Of Worldwide Rights...

Redwood City, California – (Business Wire) – March 30, 2020 – LifeMax Laboratories, Inc. (“LifeMax”), a private Company ...

June 27, 2019 

LifeMax Receives Orphan Drug Designation From the United States Food & ...

Palo Alto, California – (Business Wire) – June 27, 2019 – LifeMax Laboratories, Inc. (“LifeMax”), a private company focused ...

August 27, 2018 

LifeMax Acquires Worldwide Right to Clinical Stage Orphan Asset

Palo Alto, California – (Business Wire) - August 27, 2018 – LifeMax Laboratories, Inc. (“LifeMax”), a private company focused ...

November 13, 2019 

LifeMax Receives Orphan Drug Designation From the European...

Palo Alto, California – (Business Wire) – November 13, 2019 – LifeMax Laboratories, Inc. (“LifeMax”), a private company ...

December 3, 2018 

LifeMax Appoints Kirk Johnson, Ph.D., as VP of Preclinical Development

Palo Alto, California – (Business Wire) – December 03, 2018 – LifeMax Laboratories, Inc. (“LifeMax”), a private company ...

July 18, 2019 

LifeMax Receives Rare Pediatric Disease Designation For LM-030 ...

Palo Alto, California – (Business Wire) – July 18, 2019 – LifeMax Laboratories, Inc. (“LifeMax”), a private company focused ...

September 13, 2018 

LifeMax Appoints Laman Alani, Ph.D., as VP of Product Development

Palo Alto, California – (Business Wire) – September 13, 2018 – LifeMax Laboratories, Inc. (“LifeMax”), a private company ...

Treating Orphan Diseases Having Few or No Therapeutic Options.

map.png

Redwood City, CA, USA

map.png

Taipei, Taiwan

©2020 BY LIFEMAX HEALTHCARE INTERNATIONAL